CellCept 250 mg/1 (Mycophenolate Mofetil CAPSULE) 250 mg/1

CellCept 250 mg capsules contain mycophenolate mofetil, an immunosuppressant used to prevent organ rejection. This medication is commonly prescribed for transplant patients.

Strength

250 mg/1

Pack Size

1 BOTTLE, PLASTIC in 1 CARTON (0004-0259-43) / 500 CAPSULE in 1 BOTTLE, PLASTIC

Manufacturer / TM Owner

Genentech, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

CellCept 250 mg capsules are primarily used to prevent rejection in organ transplant patients. Mycophenolate mofetil works by suppressing the immune system, helping the body accept the transplanted organ. This medication is often used in combination with other immunosuppressants. Patients should consult their healthcare provider to understand the specific uses of CellCept in their treatment plan.

Side Effects

Common effects of CellCept 250 mg capsules may include nausea, vomiting, diarrhea, and abdominal pain. Some patients may experience fatigue or infections due to the immunosuppressant nature of the medication. It is important to monitor for any unusual symptoms and report them to a healthcare provider.

Precautions & Warnings

CellCept 250 mg capsules should be handled with care, as the medication can be harmful if crushed or inhaled. Pregnant women or those planning to become pregnant should discuss the risks with their healthcare provider, as mycophenolate mofetil can cause birth defects. Regular blood tests may be required to monitor for potential side effects.

Avoid Interactions

CellCept 250 mg capsules may interact with other medications, including antacids containing magnesium or aluminum, which can reduce the absorption of mycophenolate mofetil. Patients should avoid taking CellCept with cholestyramine, as it can decrease the effectiveness of the medication. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

CellCept 250 mg capsules are used to prevent organ rejection in transplant patients by suppressing the immune system.

CellCept 250 mg capsules should be taken orally, usually twice a day, with or without food. Follow your healthcare provider's instructions for proper administration.

Common side effects may include nausea, vomiting, diarrhea, abdominal pain, fatigue, and increased risk of infections.

CellCept 250 mg capsules can cause birth defects and should be avoided during pregnancy unless directed by a healthcare provider.

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.